The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Ravindran, A. V.
* Articles by Griffiths, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Ravindran, A. V.
* Articles by Griffiths, J.
Related Collections
* Depression
* Behavior Therapy
* Cognitive Therapy
* Antidepressants
Am J Psychiatry 156:1608-1617, October 1999
© 1999 American Psychiatric Association


Regular Article

Treatment of Primary Dysthymia With Group Cognitive Therapy and Pharmacotherapy: Clinical Symptoms and Functional Impairments

Arun V. Ravindran, M.D., Ph.D., Hymie Anisman, Ph.D., Zul Merali, Ph.D., Yoland Charbonneau, M.D., John Telner, Ph.D., Robert J. Bialik, Ph.D., Andrew Wiens, M.D., Jack Ellis, M.D., and Jenna Griffiths, Ph.D.

OBJECTIVE: This study assessed the efficacy of antidepressant treatment (sertraline) and group cognitive behavior therapy, alone or in combination, in primary dysthymia. The clinical features of dysthymia, as well as the functional impairments associated with the illness (e.g., quality of life, stress perception, coping styles), were evaluated. METHOD: Patients (N=97) diagnosed with primary dysthymia, but no other current comorbid disorder, received either sertraline or placebo in a double-blind design over 12 weeks. In addition, a subgroup of the patients (N=49) received a structured, weekly group cognitive behavior therapy intervention. RESULTS: Treatment with sertraline, with or without group cognitive behavior therapy, reduced the functional impairment of depression. The reductions were similar in the drug-cognitive therapy group and in subjects who received the drug alone. Furthermore, while group cognitive behavior therapy alone reduced the depression scores, this effect was not significantly greater than the effect of the placebo. The drug treatment also induced pronounced improvement in the functional measures, and in some respects these effects were augmented by group cognitive behavior therapy. Among patients who responded favorably to cognitive behavior therapy, the improvements in the functional measures were similar to those who responded to drug treatment, whereas such functional changes were not seen among patients who responded to placebo. CONCLUSIONS: Sertraline treatment effectively reduces the clinical symptoms and functional impairments associated with dysthymia. Although the group cognitive behavior therapy intervention was less effective in alleviating clinical symptoms, it augmented the effects of sertraline with respect to some functional changes, and in a subgroup of patients it attenuated the functional impairments characteristic of dysthymia.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
E. Frank, D. J. Kupfer, M. E. Thase, A. G. Mallinger, H. A. Swartz, A. M. Fagiolini, V. Grochocinski, P. Houck, J. Scott, W. Thompson, et al.
Two-Year Outcomes for Interpersonal and Social Rhythm Therapy in Individuals With Bipolar I Disorder
Arch Gen Psychiatry, September 1, 2005; 62(9): 996 - 1004.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
R. D. Jindal and M. E. Thase
Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Focus, January 1, 2005; 3(1): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza
Combined Pharmacotherapy and Psychological Treatment for Depression: A Systematic Review
Arch Gen Psychiatry, July 1, 2004; 61(7): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
R. D. Jindal and M. E. Thase
Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Psychiatr Serv, November 1, 2003; 54(11): 1484 - 1490.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
R. A. Remick
Diagnosis and management of depression in primary care: a clinical update and review
Can. Med. Assoc. J., November 26, 2002; 167(11): 1253 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. O. Gabbard and J. Kay
The Fate of Integrated Treatment: Whatever Happened to the Biopsychosocial Psychiatrist?
Am J Psychiatry, December 1, 2001; 158(12): 1956 - 1963.
[Abstract] [Full Text] [PDF]


Home page
J. Psychother. Pract. Res.Home page
M. E. Thase
Scientific Foundations of Cognitive Theory and Therapy of Depression
J Psychother Pract Res., October 1, 2001; 10(4): 286 - 287.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org